CM
Caption Management Portfolio holdings
AUM
$1.09B
1-Year Return
4.13%
This Quarter Return
+0.93%
1 Year Return
+4.13%
3 Year Return
+12.18%
5 Year Return
+25.84%
10 Year Return
–
AUM
$944M
AUM Growth
+$36.2M
(+4%)
Cap. Flow
+$38.2M
Cap. Flow
% of AUM
4.05%
Top 10 Holdings %
Top 10 Hldgs %
49.37%
Holding
915
New
190
Increased
95
Reduced
82
Closed
164
Top Buys
| 1 |
Alphabet (Google) Class C
GOOG
|
$42.9M |
| 2 |
First Solar
FSLR
|
$19.1M |
| 3 |
Charter Communications
CHTR
|
$19M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$15.3M |
| 5 |
Alnylam Pharmaceuticals
ALNY
|
$13.7M |
Top Sells
| 1 |
Meta Platforms (Facebook)
META
|
$25.5M |
| 2 |
Pilgrim's Pride
PPC
|
$18.9M |
| 3 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$18.2M |
| 4 |
Zillow
Z
|
$12.8M |
| 5 |
Cytokinetics
CYTK
|
$10.8M |
Sector Composition
| 1 | Communication Services | 21.88% |
| 2 | Healthcare | 20.75% |
| 3 | Financials | 13.93% |
| 4 | Technology | 13.09% |
| 5 | Consumer Discretionary | 6.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
276
GXO Logistics
GXO
$5.98B
| $202K | ﹤0.01% |
+4,000
| New | +$202K |
|
277
Arm
ARM
$147B
| $196K | ﹤0.01% |
+1,200
| New | +$196K |
|
278
PTC Therapeutics
PTCT
$4.52B
| $193K | ﹤0.01% |
+6,300
| New | +$193K |
|
279
MP Materials
MP
$11.1B
| $191K | ﹤0.01% |
+15,000
| New | +$191K |
|
280
Xcel Energy
XEL
$42.4B
| $187K | ﹤0.01% |
3,500
-11,000
| -76% | -$588K |
|
281
Nordic American Tanker
NAT
$688M
| $179K | ﹤0.01% |
45,000
+38,000
| +543% | +$151K |
|
282
Applied Digital
APLD
$3.64B
| $179K | ﹤0.01% |
30,000
-40,000
| -57% | -$238K |
|
283
Anterix
ATEX
$413M
| $178K | ﹤0.01% |
+4,500
| New | +$178K |
|
284
Samsara
IOT
$23.6B
| $173K | ﹤0.01% |
+5,139
| New | +$173K |
|
285
Darling Ingredients
DAR
$4.94B
| $173K | ﹤0.01% |
4,700
-39,740
| -89% | -$1.46M |
|
286
Phreesia
PHR
$1.6B
| $173K | ﹤0.01% |
8,145
-36,855
| -82% | -$781K |
|
287
Encompass Health
EHC
$12.7B
| $172K | ﹤0.01% |
2,000
-8,000
| -80% | -$686K |
|
288
Cardlytics
CDLX
$48.5M
| $167K | ﹤0.01% |
+20,307
| New | +$167K |
|
289
ImmunityBio
IBRX
$2.28B
| $165K | ﹤0.01% |
26,032
-47,622
| -65% | -$301K |
|
290
Best Buy
BBY
$16.4B
| $164K | ﹤0.01% |
+1,944
| New | +$164K |
|
291
Elevance Health
ELV
$69.4B
| $163K | ﹤0.01% |
+300
| New | +$163K |
|
292
The GEO Group
GEO
$2.93B
| $161K | ﹤0.01% |
+11,200
| New | +$161K |
|
293
Advanced Drainage Systems
WMS
$11.5B
| $160K | ﹤0.01% |
+1,000
| New | +$160K |
|
294
Ocular Therapeutix
OCUL
$2.21B
| $157K | ﹤0.01% |
+22,900
| New | +$157K |
|
295
Apyx Medical
APYX
$77.9M
| $155K | ﹤0.01% |
115,550
-558
| -0.5% | -$748 |
|
296
Novavax
NVAX
$1.26B
| $152K | ﹤0.01% |
12,000
-9,698
| -45% | -$123K |
|
297
Caterpillar
CAT
$198B
| $147K | ﹤0.01% |
+440
| New | +$147K |
|
298
MacroGenics
MGNX
$111M
| $146K | ﹤0.01% |
+34,400
| New | +$146K |
|
299
NexGen Energy
NXE
$4.55B
| $145K | ﹤0.01% |
20,832
-23,368
| -53% | -$163K |
|
300
Guess, Inc.
GES
$881M
| $141K | ﹤0.01% |
6,900
-8,221
| -54% | -$168K |
|